The Minister of Health, Ginés González García, announced that Our country was chosen by the World Health Organization (WHO) as one of the ten that will do a universal clinical trial to try to cure Coronavirus COVID-19.
Speaking to TN, González García said: “Norway, Canada, France, Thailand, some other countries and we are entering. We are countries that are going to try treatment therapy alternatives. The world’s first clinical trial. ”
In this sense, he explained the scope that these studies may have. “For example, There is a French man who talks about hydroxychloroquineOthers say that there is an antiviral that was used for HIV carriers, others that such something else could work, such as a new drug that Trump says the United States has. So doing a clinical trial means trying therapeutic alternatives with population groups and seeing which one has the best effect “.
On the choice of Argentina to be part of this important study, he stated: “Our advantage is not only having been elected for previous reasons that have to do with the quality of the country, but We will be in the first line when we have the conclusion of which is the best therapy. That is an advantage. But it’s going to take a little bit. ”
He also confirmed that, as in France, Hydroxychloroquine is being tested in Argentina as one of the drugs that could cure the disease. “We are treating some seriously ill patients with hydroxychloroquine at the Posadas hospital, but we still cannot, with a denominator as small as three cases are, draw conclusions.”
“Hydroxychloroquine,” said Ginés, “is a very old antimalarial that is used against malaria, against some pathologies such as lupus, which has an anti-inflammatory capacity. It is an ancient drug that is said to have some positive effect. Some say it more emphatically, others don’t. I cannot make a value judgment. But we can’t stop trying anything. ”
“We meet with all the experts. I have summoned all the scientists. With the indications that we have, there is already a therapy put on the page so that all the provinces can use it. But as we become more knowledgeable, especially after this study, which is global, rabid, a clinical trial technique but one that gives a drug a lot of truth, which is what is done, “he added.
The Ministry of Health contacted the best epidemiologists, infectious diseases that the World Health Organization was able to approach us, and we were acting as those who know best recommended us. So we did it.
The director general of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, announced this large global clinical trial against a disease that has already caused deaths.
At a press conference, Tedros stressed that “This large international study is designed to generate the solid data we need, to show which treatments are the most effective.”.
Spain, Argentina, Bahrain, Canada, France, Iran, Norway, South Africa, Switzerland and Thailand are the countries that the World Health Organization chose for the important work, which will be known as ‘Solidarity’ (solidarity in Spanish). They will be at the forefront of the experiments, and the WHO director-general confided that “many more countries will join.” The trial will be simple enough so that even hospitals that are on the edge of receiving patients can implement it.
“The first vaccine trial has started just 60 days after the coronavirus gene sequence was shared. This is an incredible achievement. We commend researchers around the world who have come together to systematically evaluate experimental therapies. But multiple small trials with different methods may not give us the clear and strong evidence we need on what treatments help save lives. “Tedros noted about the scope of this study.
For the WHO, in addition to the important of these clinical trials, flattening the curve is the most important approach to fighting the pandemic. “This approach is saving lives and buying time for the development of vaccines and treatments,” he said.